PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
1.43 - 1.45
1.18 - 2.36
880.0K / 1.73M (Avg.)
-18.00 | -0.08
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
14114.39%
Positive revenue growth while 1177.HK is negative. John Neff might see a notable competitive edge here.
-38888.36%
Both firms have negative gross profit growth. Martin Whitman would question the sector’s viability or cyclical slump.
No Data
No Data available this quarter, please select a different quarter.
-212.09%
Negative operating income growth while 1177.HK is at 25.83%. Joel Greenblatt would press for urgent turnaround measures.
-439.49%
Negative net income growth while 1177.HK stands at 32.22%. Joel Greenblatt would push for a reevaluation of cost or revenue strategies.
-438.03%
Negative EPS growth while 1177.HK is at 32.29%. Joel Greenblatt would expect urgent managerial action on costs or revenue drivers.
-438.03%
Negative diluted EPS growth while 1177.HK is at 32.29%. Joel Greenblatt would require immediate efforts to restrain share issuance or boost net income.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
61.25%
OCF growth of 61.25% while 1177.HK is zero. Bruce Berkowitz would see if small gains can expand into a larger competitive lead.
52.52%
FCF growth of 52.52% while 1177.HK is zero. Bruce Berkowitz would see if modest improvements in free cash can accelerate further.
-92.12%
Negative 10Y revenue/share CAGR while 1177.HK stands at 0.00%. Joel Greenblatt would question if the company is failing to keep pace with industry changes.
-93.31%
Negative 5Y CAGR while 1177.HK stands at 218.94%. Joel Greenblatt would push for a turnaround plan or reevaluation of the company’s product line.
No Data
No Data available this quarter, please select a different quarter.
-589.49%
Negative 10Y OCF/share CAGR while 1177.HK stands at 0.00%. Joel Greenblatt would scrutinize managerial effectiveness and product competitiveness.
-125.25%
Negative 5Y OCF/share CAGR while 1177.HK is at 325.87%. Joel Greenblatt would question the firm’s operational model or cost structure.
No Data
No Data available this quarter, please select a different quarter.
-128.25%
Negative 10Y net income/share CAGR while 1177.HK is at 0.00%. Joel Greenblatt sees a major red flag in long-term profit erosion.
-289.32%
Negative 5Y net income/share CAGR while 1177.HK is 353.23%. Joel Greenblatt would see fundamental missteps limiting profitability vs. the competitor.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-100.00%
Both lowered dividends mid-term. Martin Whitman might suspect broad sector constraints or strategic shifts from dividends.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
820.38%
We expand SG&A while 1177.HK cuts. John Neff might see the competitor as more cost-optimized unless we expect big payoffs from the overhead growth.